Literature DB >> 11063488

Comparison of a chemiluminescent immunoassay with two microparticle enzyme immunoassays for detection of hepatitis B virus surface antigen.

R J Diepersloot1, Y van Zantvliet-van Oostrom, C A Gleaves.   

Abstract

A comparative evaluation of the following commercial immunoassays for the detection of hepatitis B virus surface antigen (HBsAg) was performed: the Abbott AxSYM, Abbott IMx, and DPC IMMULITE assays. The specificity was 100% for all assays. Twelve samples were identified and were confirmed to be positive for HBsAg by all three methods. One additional sample was identified as reactive and was confirmed to be positive by the Abbott AxSYM assay only. Prior to confirmation testing the DPC IMMULITE assay produced significantly fewer false-positive results than the Abbott AxSYM assay (P < 0.05).

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11063488      PMCID： PMC95975          DOI： 10.1128/CDLI.7.6.865-866.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  2 in total

1.  The IMMULITE assay tube: a new approach to heterogeneous ligand assay.

Authors:  A L Babson; D R Olson; T Palmieri; A F Ross; D M Becker; P J Mulqueen
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

2.  The Abbott IMx automated benchtop immunochemistry analyzer system.

Authors:  M Fiore; J Mitchell; T Doan; R Nelson; G Winter; C Grandone; K Zeng; R Haraden; J Smith; K Harris
Journal:  Clin Chem       Date:  1988-09       Impact factor: 8.327
  2 in total
  6 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

3.  HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt.

Authors:  Eman Ae Abushady; Magda Ma Gameel; John D Klena; Salwa F Ahmed; Kouka Se Abdel-Wahab; Sanya M Fahmy
Journal:  World J Hepatol       Date:  2011-06-27

4.  A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review.

Authors:  Sonia Roman; Arturo Panduro; Yadira Aguilar-Gutierrez; Montserrat Maldonado; Maclovia Vazquez-Vandyck; Erika Martinez-Lopez; Bertha Ruiz-Madrigal; Zamira Hernandez-Nazara
Journal:  Hepatol Int       Date:  2008-12-19       Impact factor: 6.047

Review 5.  Update on hepatitis B and C virus diagnosis.

Authors:  Livia Melo Villar; Helena Medina Cruz; Jakeline Ribeiro Barbosa; Cristianne Sousa Bezerra; Moyra Machado Portilho; Letícia de Paula Scalioni
Journal:  World J Virol       Date:  2015-11-12

6.  Distribution Characteristics of Hepatitis B Serological Markers in Hospitalized Children and Adolescents in Zhejiang, China between 2006 and 2010.

Authors:  Xuejun Chen; Yuefang Shen; Wenqing Xiang
Journal:  Gut Liver       Date:  2011-06-23       Impact factor: 4.519
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.